Enhanced ultrasound treatment of chronic wounds with monitoring of healing and quality of life outcomes
Enhanced ultrasound treatment of chronic wounds with monitoring of healing and quality of life outcomes
批准号:
9473400
负责人:
Peter A. Lewin
金额:
$2.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-27 至 2021-06-30
关键词:
Adjuvant TherapyAffectArtificial skinBecaplerminBiomedical EngineeringBlood VesselsBlood flowCaregiversCaringCharacteristicsChronicClinicalCustomDataDecubitus ulcerDevelopmentDevicesDiabetes MellitusDiabetic Foot UlcerDiabetic ulcerDiagnosticDiffuseDiscipline of NursingDiseaseDouble-Blind MethodEpidemiologyExposure toFoundationsFrequenciesFutureGeneric DrugsGuidelinesHealthHumanImpaired wound healingIndividualInflammationInflammatoryInterdisciplinary StudyInterventionLinkMalnutritionMeasuresMethodsMissionMonitorMorbidity - disease rateNear-Infrared SpectroscopyNecrosisNursesNutritionalNutritional statusOperative Surgical ProceduresOptical MethodsOpticsOutcomePatientsPerfusionPhysicsPhysiologicalPlacebosPlatelet-Derived Growth FactorQuality of lifeRandomized Clinical TrialsRandomized Controlled TrialsResearchSafetySocietiesSpecificitySurfaceSystemTestingTherapeuticTherapeutic AgentsTherapeutic UsesTimeTissuesTranslatingTreatment ProtocolsUltrasonic TherapyUltrasonicsUltrasonographyVaricose UlcerWorkWound Healingangiogenesisblood perfusionchronic woundcostcost effectivedisabilityeffective therapyevidence basehealinghealth related quality of lifehemodynamicsimprovedindividualized medicineinnovationlight weightnon-healing woundsnoninvasive diagnosisnovelnovel therapeuticsnutritionpersonalized medicineportabilitypreventprogramsreduce symptomsstandard caretissue oxygenationwoundwound closure
中文摘要
项目摘要/摘要
两种最常见的慢性创面是静脉性溃疡(VUS)和糖尿病溃疡(DU)。我们
将进行首个双盲随机对照试验(RCT),以测试低频率、低剂量和低剂量药物的疗效
强度超声(US)对慢性创面愈合和健康相关生活质量(HRQOL)的影响
统计置信度(α<;0.05,Power>;0.90,n=60vus,n=60Dus)。我们的方法结合了这一主动
在整个治疗周期中对伤口血流动力学进行非侵入性诊断监测的治疗,以及
包括营养状况和炎症对伤口闭合的影响的分析。有几个
这项工作的创新之处。具体地说,(1)我们的轻巧、电池供电的涂抹器是第一个
潜在的可穿戴的超声波创伤治疗设备,可以安全地长时间应用。(2)
该敷贴器积极地促进愈合,这与商业超声波系统有根本的不同
只能去除坏死组织。(3)我们的方法将把Lfli US暴露与伤口的变化联系起来
血流动力学和HRQOL,这有可能使个性化药物。(4)我们对
患者的营养和全身炎症状态可以通过确定
那些最有可能从LFli US治疗中受益的患者。(5)我们的方法结合了针对疾病的
以及HRQOL的通用测量,这是治疗性超声随机对照试验所独有的。
我们的低频、低强度(20 kHz,<;100 mW/cm2空间峰值-时间峰值)便携式超声波
敷贴器是一种安全实用的创面治疗方法。田野
轻量级(<;25g)和许可证
我们的US设备的参数之前针对静脉溃疡进行了优化,最近进行了三次临床试验
人体研究(vus:n=20,n=25;Dus:n=10)显示,我们的治疗可使愈合率提高15%。
一周与假治疗相比。因此,我们预计我们的治疗将加速关闭
慢性创面,我们假设(1)LFli US将改善普通和疾病特异性HRQOL
评分,(2)LFli US将激活伤口及其周围微血管的有益变化
组织,以及(3)营养不良和高度炎症的人将延迟伤口愈合。
我们的具体目标是:(1)通过测量伤口闭合程度来评估LFli US对VUS和Dus的影响。
作为主要终点,通用和疾病特有的HRQOL作为次要终点。(2)监控
应用非侵入性光学方法研究LFli US对伤口血流和氧合的影响,以及(3)确定
营养状况和炎症对DUS和VUS关闭的影响。总体而言,这项工作将验证
LFli US是一种安全、便携和成本效益高的慢性伤口治疗方法。这很重要,因为新的
迫切需要创面处理的治疗方法和改进的临床范例。从长远来看,
我们的发现可能有助于开发跨护理环境的个性化伤口治疗方案。
英文摘要
Project Summary / Abstract
The two most common types of chronic wounds are venous ulcers (VUs) and diabetic ulcers (DUs). We
will conduct the first double-blind randomized controlled trial (RCT) to test the effect of low-frequency, low-
intensity (LFLI) ultrasound (US) on chronic wound healing and health related quality of life (HRQOL) with high
statistical confidence (α < 0.05, power > 0.90, n=60 VUs, n=60 DUs). Our approach combines this active
therapy with non-invasive diagnostic monitoring of wound hemodynamics throughout the treatment cycle, and
includes analysis of the impact of nutritional status and inflammation on wound closure. There are several
innovative aspects of this work. Specifically, (1) Our lightweight, battery-powered applicator is the first
potentially wearable ultrasound wound therapy device that is safe to apply for extended periods of time. (2)
The applicator actively promotes healing, which is fundamentally different from commercial ultrasonic systems
that remove necrotic tissue only. (3) Our approach will link LFLI US exposure to changes in wound
hemodynamics and HRQOL, which has the potential to enable personalized medicine. (4) Our analysis of
patient nutritional and systemic inflammatory status may enable further treatment customization by identifying
those patients most likely to benefit from LFLI US therapy. (5) Our approach incorporates both disease-specific
and generic measures of HRQOL, which is unique for a therapeutic ultrasound RCT.
Our low-frequency, low-intensity (20 kHz, <100 mW/cm2 spatial peak-temporal peak), portable ultrasound
applicator is safe and clinically pragmatic wound treatment. The field
lightweight (<25g) and permits
parameters of our US device were previously optimized for venous ulcers, and our three recent pilot clinical
human studies (VUs: n=20, n=25; DUs: n=10) demonstrated that our treatment improved healing by 15% per
week compared to sham treatment. We therefore anticipate that our treatment will accelerate closure of
chronic wounds, and we hypothesize that (1) LFLI US will improve generic and disease-specific HRQOL
scores, (2) LFLI US will activate beneficial changes in the microvasculature of the wound and surrounding
tissue, and (3) individuals with poor nutrition and high levels of inflammation will have delayed wound healing.
Our specific aims are to: (1) Assess the effect of LFLI US on VUs and DUs by measuring wound closure
as a primary endpoint and generic and disease-specific HRQOL as secondary endpoints. (2) Monitor the
effects of LFLI US on wound perfusion and oxygenation using non-invasive optical methods, and (3) Determine
the impact of nutritional status and inflammation on closure of DUs and VUs. Overall, this work will validate
LFLI US as a safe, portable, and cost-effective therapy for chronic wounds. This is important because new
therapies and improved clinical paradigms for wound management are urgently needed. Over the long-term,
our findings may enable the development of personalized wound treatment regimens across care settings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Acousto-optic Theragnostic Approach for Chronic Wound Management
-
批准号:8274743
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2010
-
负责人:Peter A. Lewin
-
依托单位:
Acousto-optic Theragnostic Approach for Chronic Wound Management
-
批准号:8464100
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2010
-
负责人:Peter A. Lewin
-
依托单位:
Acousto-optic Theragnostic Approach for Chronic Wound Management
-
批准号:7886050
-
项目类别:
-
资助金额:$46.88万
-
财政年份:2010
-
负责人:Peter A. Lewin
-
依托单位:
Acousto-optic Theragnostic Approach for Chronic Wound Management
-
批准号:8062002
-
项目类别:
-
资助金额:$47.83万
-
财政年份:2010
-
负责人:Peter A. Lewin
-
依托单位:
100 MHz Acousto-optic Hydrophone Probe for Biomedical Ultrasound Applications
-
批准号:7129768
-
项目类别:
-
资助金额:$32.0万
-
财政年份:2006
-
负责人:Peter A. Lewin
-
依托单位:
100 MHz Acousto-optic Hydrophone Probe for Biomedical Ultrasound Applications
-
批准号:7465348
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2006
-
负责人:Peter A. Lewin
-
依托单位:
100 MHz Acousto-optic Hydrophone Probe for Biomedical Ultrasound Applications
-
批准号:7281167
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2006
-
负责人:Peter A. Lewin
-
依托单位:
ULTRASOUND HYDROPHONE AND ITS CALIBRATION UP TO 100 MHz
-
批准号:6648377
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2001
-
负责人:Peter A. Lewin
-
依托单位:
ULTRASOUND HYDROPHONE AND ITS CALIBRATION UP TO 100 MHz
-
批准号:6415671
-
项目类别:
-
资助金额:$23.05万
-
财政年份:2001
-
负责人:Peter A. Lewin
-
依托单位:
ULTRASOUND HYDROPHONE AND ITS CALIBRATION UP TO 100 MHz
-
批准号:6529948
-
项目类别:
-
资助金额:$23.49万
-
财政年份:2001
-
负责人:Peter A. Lewin
-
依托单位:
DEVELOPMENT OF WIDEBAND TRANSDUCERS FOR MEDICAL IMAGING
-
批准号:6327605
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2000
-
负责人:Peter A. Lewin
-
依托单位:
DEVELOPMENT OF WIDEBAND TRANSDUCERS FOR MEDICAL IMAGING
-
批准号:6203179
-
项目类别:
-
资助金额:$26.78万
-
财政年份:1999
-
负责人:Peter A. Lewin
-
依托单位:
DEVELOPMENT OF WIDEBAND TRANSDUCERS FOR MEDICAL IMAGING
-
批准号:6102620
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:Peter A. Lewin
-
依托单位:
海外基金